Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigious | ||
Readability |
H.S. sophomore Avg
|
New words:
absence, accuracy, acid, adjourned, ADVIL, affirmed, agent, Alabama, allele, American, aminocarboxylic, amortized, andPONDIMIN, andPREMARIN, andXYNTHA, AOCI, Apolipoprotein, appraisal, arising, attain, bacterial, Biologic, blended, broadly, CAFC, calculation, CALTRATE, canceled, category, Chancery, chelating, Civil, CJ, collateral, column, component, composed, comprehensive, consummate, consummated, consummation, copy, correct, counterbalance, counterparty, criteria, CV, Cy, Del, Department, dextromethorphan, diamine, Diphtheria, disrupt, disruption, diversifying, divestiture, dosage, edema, Eli, eligible, entiretyRule, ethylene, exhibit, expedited, extent, failure, FAS, fee, financing, Fla, flow, foregoing, formal, forPREVNAR, forPRISTIQfor, forXYNTHA, fracture, France, franchisesENBREL, fromBENEFIX, fromBENEFIXof, fromPREVNAR, FTC, FX, genericPROTONIX, genetic, GOLD, GOLDandPROMIL, hardship, headcount, heightened, highest, Home, household, inAccumulated, inception, includingENBREL, incurrence, indirectly, inflammation, ininterest, inLilly, inPREVNAR, inPROTONIXbetween, inResearch, inSelling, instrument, interference, internationalEFFEXOR, internationalZOSYN, intervened, Intervening, intervention, irrespective, issuable, issuer, Justice, launchCONBRIZA, lesser, lieu, lifelong, Likewise, Lilly, lowerENBREL, mentioned, merge, merger, metabolism, Mexico, minimize, minimized, minimizing, misuse, mitigate, Montgomery, Moody, movement, musculoskeletal, Mylan, Nanterre, negotiated, neratinib, neurodegenerative, neuroscience, neutralize, notional, objective, ofAccumulated, ofPREMARINorPREMPRO, ofPRIMATENE, ofZOSYNprior, opportunistic, opposite, orderly, ordinary, Organization, outlook, overState, passed, piperacillin, placement, portion, post, preclinical, precondition, PRIMATENEin, productPROHEART, progestin, prolonged, promissory, proper, properly, Protein, PTO, purported, reclassified, recognition, redemption, referenced, regimen, reintroduced, relationship, rely, relying, replicated, reproduced, rescind, retained, revolving, satisfaction, seal, sealedqui, separatingROBITUSSINinto, Sepracor, single, situation, slowdown, slowly, stable, stop, stretched, stronger, substance, succinate, summarize, summarized, susceptible, swap, tazobactam, testing, tetraacetic, Thailand, theEFFEXORfamily, thequi, tighter, timeframe, timetable, TNF, toPREVNAR, Torrent, Trademark, trimegestone, Tulsa, tumor, unaffiliated, understood, unemployment, unpaid, unrealized, unsecured, validly, vasogenic, vest, veterinary, vi, volatility, waiting, watch, wholly, withPROHEART, Wockhardt
Removed:
achieved, actively, adapt, andPONDIMINdiet, approach, approvedPRISTIQ, AWP, bromide, build, calicheamicin, combination, combined, commercially, compensatory, consolidation, continuously, contraceptive, County, Daniel, decreasedPROTONIX, decreasing, Deferral, designed, equine, estradiol, existed, extending, fiscal, follicular, forANYA, formulated, forRELISTOR, forXYNTHAin, found, fromEFFEXOR, fundamentally, HCl, hereof, initiate, injection, innovate, inotuzumab, intention, IRS, launching, laxative, lymphoma, manufactured, matter, methylnaltrexone, mg, mortality, nanofiltration, network, nonfinancial, ofPREMARINandPREMPRO, order, ourEFFEXOR, ozogamicin, Pennsylvania, percent, poultry, practice, punitive, purification, reflecting, resistant, retrospectively, returned, spending, submitting, suit, supportingTYGACIL, technology, toxicity, workforce
Filing tables
Filing exhibits
- 10-Q Quarterly report
- 12 Computation of Ratio of Earnings to Fixed Charges
- 31.1 Certification of Disclosure As Adopted Pursuant to Section 302
- 31.2 Certification of Disclosure As Adopted Pursuant to Section 302
- 32.1 Certification As Adopted Pursuant to Section 906
- 32.2 Certification As Adopted Pursuant to Section 906
Related press release
WYE similar filings
Filing view
External links